Myonexus Therapeutics' Seed VC Round

Myonexus Therapeutics raised a round of funding on December 13, 2017.

Myonexus Therapeutics is a clinical stage gene therapy company developing treatments for Limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children's H…

Articles about Myonexus Therapeutics' Seed VC Round: